Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,522.40
(
0.33%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
-0.89%
)
Bitcoin
73,420.16
(
-0.16%
)
News Focus
News Focus
Post# of 448124
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JRoon71

Send PM Follow Ignore
Followers 22
Posts 4699
Boards Moderated 0
Alias Born 01/27/2022

JRoon71

Re: Birdbrain Ideas post# 432415

Friday, 01/17/2025 2:56:58 PM

Friday, January 17, 2025 2:56:58 PM

Post# of 448124

If the article is wrong, Amarin should get them to correct it.



BBI, you know how many things are "out there" that Amarin needs to correct?

Damn, let's just start with all the articles and websites calling generic IPE "Generic Vascepa", or talking about how it helps prevent cardiovascular disease.

I think Amarin gave up even trying to fix this shit years ago.

Again, this is why I always go back to my contention that the new formulation is the future for Vascepa. If there's no generic, there can be no confusion.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News